WSJ Interview with Stryker’s CEO
The Wall Street Journal has an interview today with Kevin Lobo, the CEO of Stryker (SYK). This is an interesting time for Stryker. The company just made a big bet on robotics by buying MAKO Surgical. The beginning of Obamacare also presents a significant challenge for Stryker with the new 2.3% excise tax on device sales. On the other hand, more insured people could bring greater demand for Stryker’s products.
Here are some highlights from the interview:
WSJ: Is the Affordable Care Act a net positive or a net negative for Stryker?
Mr. Lobo: For Stryker, the device tax is clearly a negative. It’s 2.3% of sales, roughly $100 million a year, which represents roughly 20% of our [research-and-development] budget. It’s a very significant burden. Clearly, it does have an impact in jobs, not just within Stryker, but within the broader industry.
The move away from pay-for-service to paying for outcomes, that’s a positive trend. There are many sensible elements of this legislation that I think will have long-term benefits, but clearly the med-device tax is the one area that is very punitive for us.
WSJ: Are you personally advocating for a repeal?
Mr. Lobo: Yes. Stryker and in conjunction with AdvaMed as part of the AdvaMed trade association, we are advocating for repeal. It’s a tax and it’s a punitive tax, especially in tax on revenue.
It also disproportionately hurts Stryker vis-à-vis my competitors, because 65% of our sales are in the United States. It’s a U.S. tax, and we have a tremendously high-performing business in the U.S., so it’s disproportionate to us.
WSJ: Next year, it’s expected that millions more people in the U.S. will have health insurance under the new health-care law. Is that a good thing or a bad thing for device makers?
Mr. Lobo: For our [hospital] bed business, there could be a benefit. Within the Affordable Care Act, there’s a provision for patient satisfaction. If hospitals don’t achieve a certain level of patient satisfaction, they’ll get a reduction in their Medicare reimbursement. A bed has a lot to do with a patient’s satisfaction, when they talk about their experience.
We also believe the knee [replacement] business could benefit as well, because that’s a more elective procedure. We’re hopeful that those patients will start to come into the health-care system and the knee volumes would grow.
WSJ: Are there a lot of uncomfortable beds out there in U.S. hospitals?
Mr. Lobo: Well, it’s not necessarily that they’re uncomfortable, but a bed is not just a bed anymore. Beds have an amazing amount of software in them. Today, many hospitals will actually have a [person] in the room with [an older or unconscious] patient to make sure the patient doesn’t fall off the bed. We have technology that, if the patient moves, can send a signal to the nurse station, and the nurse can quickly arrive on the scene.
WSJ: The device industry is criticized for a lack of transparency in pricing. A hip in one city costs one price, and a hip across the river costs 20 times as much. Are those criticisms fair?
Mr. Lobo: When I look at our price bands, we don’t see that kind of variation. That may have existed many years ago, but…. our price band is actually quite compressed right now. If you look at the device itself, it typically is less than 25% of the cost of the total procedure. We sometimes get tarnished [for] that variation, and it gets ascribed to the device when it really shouldn’t.
WSJ: Some analysts have questioned the high premium you paid for MAKO Surgical and Stryker’s stock price fell 2.8% the day the deal was announced. What makes you think that the deal is worth the price?
Mr. Lobo: It’ll provide for better implant positioning, more consistent, more reproducible outcomes [and] improve the surgeon experience. Yes, the price point was fully valued in this deal, but we believe the potential is enormous and it can really provide significant differentiation for us. This is a long-term strategic bet and I have the full support of our board.
WSJ: Your predecessor recruited you from Johnson & Johnson to Stryker in 2011. When you joined the company, did you ever think that you would be CEO?
Mr. Lobo: Yes, I did. I didn’t expect that it would happen this quickly. The goal really was to come in, to be the group president of orthopedics, to run that business, to grow that business, and to have an impact on Stryker. I did have aspirations. [Former CEO Stephen MacMillan] and I talked about that when I was hired, that this would be something that could be in the future. It just occurred a little earlier than planned.
WSJ: What’s been the most difficult part of having the top job?
Mr. Lobo: The biggest challenge of being the CEO of a med-tech company is just the demands on your time—the sheer demands that come at you, whether it’s from investors, from analysts, from employees, from the media. It’s unlike anything I’ve experienced previously.
Posted by Eddy Elfenbein on October 2nd, 2013 at 1:03 pm
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
- Tweets by @EddyElfenbein
-
Archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005